Back
Fox Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
55
FOXA
Fox
Last Price:
$49.17
Seasonality Move:
0.6%
Buy
63
RYTM
Rhythm Pharmaceuticals
Last Price:
$63.69
Seasonality Move:
15.42%
Buy
63
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals [RYTM] share price is $63.76. The Score for RYTM is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $63.76Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
FOXA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.31 | Sell |
Relative Strength Index (14 RSI): | 44.95 | Sell |
Chaikin Money Flow: | 2327380 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (48.14 - 54.4) | Sell |
Bollinger Bands (100): | (47.64 - 54.48) | Sell |
RYTM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.28 | Buy |
Relative Strength Index (14 RSI): | 63.66 | Buy |
Chaikin Money Flow: | 369446 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (52.02 - 61.16) | Buy |
Bollinger Bands (100): | (53.03 - 59.91) | Buy |
FOXA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.59 | Buy |
20-day SMA: | 50.5 | Sell |
50-day SMA: | 53.14 | Sell |
200-day SMA: | 45.9 | Buy |
8-day EMA: | 48.92 | Buy |
20-day EMA: | 50.08 | Sell |
50-day EMA: | 51.32 | Sell |
200-day EMA: | 46.5 | Buy |
RYTM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 61.43 | Buy |
20-day SMA: | 57.42 | Buy |
50-day SMA: | 55.27 | Buy |
200-day SMA: | 53.46 | Buy |
8-day EMA: | 61.16 | Buy |
20-day EMA: | 58.64 | Buy |
50-day EMA: | 56.64 | Buy |
200-day EMA: | 52.62 | Buy |
Fox Earnings Growth & FOXA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.31 per share, an increase this year of $1.06 per share, and a decrease next year of $0.33 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.07 per share, an increase this year of $1.54 per share, and an increase next year of $1.14 per share.
Fox Technical Analysis
Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Rhythm Pharmaceuticals Technical Analysis
Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |